Skip to Main Content

Paper Details

Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology.
Oncotarget
13
2015
Author NameAffiliation
Paul T FantaCenter for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center
Richard B SchwabCenter for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center
Teresa HelstenCenter for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center
Scott M LippmanCenter for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego Moores Cancer Center
  • 1 - 4

Datasets